Veracyte Inc (VCYT)
20.35
+0.16
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
20.35
0.00 (0.00%)
After-Hours: 20:00
Veracyte Cash and Short Term Investments (Quarterly): 216.45M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 216.45M |
| September 30, 2023 | 202.46M |
| June 30, 2023 | 191.14M |
| March 31, 2023 | 177.89M |
| December 31, 2022 | 178.85M |
| September 30, 2022 | 170.11M |
| June 30, 2022 | 164.00M |
| March 31, 2022 | 163.62M |
| December 31, 2021 | 177.16M |
| September 30, 2021 | 164.03M |
| June 30, 2021 | 327.54M |
| March 31, 2021 | 324.06M |
| December 31, 2020 | 349.36M |
| September 30, 2020 | 345.08M |
| June 30, 2020 | 147.45M |
| March 31, 2020 | 153.13M |
| December 31, 2019 | 159.32M |
| September 30, 2019 | 195.66M |
| June 30, 2019 | 192.65M |
| March 31, 2019 | 67.84M |
| December 31, 2018 | 78.00M |
| September 30, 2018 | 77.85M |
| Date | Value |
|---|---|
| June 30, 2018 | 23.76M |
| March 31, 2018 | 27.15M |
| December 31, 2017 | 33.89M |
| September 30, 2017 | 41.20M |
| June 30, 2017 | 46.46M |
| March 31, 2017 | 51.51M |
| December 31, 2016 | 59.22M |
| September 30, 2016 | 31.70M |
| June 30, 2016 | 38.99M |
| March 31, 2016 | 47.46M |
| December 31, 2015 | 39.08M |
| September 30, 2015 | 46.12M |
| June 30, 2015 | 51.04M |
| March 31, 2015 | 25.80M |
| December 31, 2014 | 35.01M |
| September 30, 2014 | 44.00M |
| June 30, 2014 | 58.00M |
| March 31, 2014 | 64.24M |
| December 31, 2013 | 71.22M |
| September 30, 2013 | 15.43M |
| June 30, 2013 | 20.68M |
| December 31, 2012 | 14.00M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
147.45M
Minimum
Jun 2020
349.36M
Maximum
Dec 2020
210.52M
Average
178.85M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Fonar Corp | 53.26M |
| XWELL Inc | 23.05M |
| ProPhase Labs Inc | 4.736M |
| Applied DNA Sciences Inc | 3.359M |
| OncoCyte Corp | 9.432M |